Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression.
Liu F, Liao Z, Qin L, Zhang Z, Zhang Q, Han S, Zeng W, Zhang H, Liu Y, Song J, Chen W, Zhu H, Liang H, Chen X, Zhang B, Zhang Z.
Liu F, et al. Among authors: chen w, chen x.
Hepatology. 2023 Nov 1;78(5):1384-1401. doi: 10.1097/HEP.0000000000000268. Epub 2023 Jan 13.
Hepatology. 2023.
PMID: 36631007
Free PMC article.